Probability models are extended for periodic cancer screening trials to model sensitivity when it is changing with an individual's age and time spent in the preclinical state. Wu et al. (2005) showed that sensitivity is monotone increasing with age, but intuitively, sensitivity is also a function of the time one has spent in the preclinical stage. This allows us to infer sensitivity at a late stage, just before symptoms manifest. We developed the probability model and applied Bayesian inference to the HIP study group data. The methodology we developed is also applicable to other kinds of chronic diseases.
Introduction
Early detection and treatment may be effective ways to decrease mortality rate from cancer. The primary technique for early detection is screening exams. According to a recent report of the National Institute of Health (NIH 2000) , breast cancer is the most common form of cancer among women in the United States and the second leading cause of cancer deaths among women. In the past four decades, seven major randomized controlled breast cancer screening trials have been carried out in North America and Europe.
In a screening program, a large group of asymptomatic individuals are enrolled in the program to detect the presence of a specific disease. The natural history of the disease for an individual is assumed to follow a progressive stochastic model, which consists of three states, respectively, to the disease-free state; the preclinical disease state, in which an asymptomatic individual unknowingly has disease that the screening exam can detect; and the clinical state when the disease manifests itself in clinical symptoms. The sensitivity is the probability that the screening exam is positive given that the individual is in the preclinical stage.
The sojourn time refers to the time beginning when the disease first develops until the manifestation of clinical symptoms, that is ) ( p c S S − . The transition probability into the preclinical stage is the probability density function of making transition from the diseasefree to the preclinical state. Knowledge of the sensitivity of the screening modality is necessary for evaluating the predictive performance of a screening exam. The screening sensitivity may depend on a variety of factors, including age, position, location and size of the tumor, the experience of the radiologist, etc. For example, recent studies indicate that the sensitivity of mammography increases with age at diagnosis (Wu et al., 2005; Shapiro et al., 1988; Miller et al., 1992a Miller et al., , 1992b , attributable to the fact that breast tissue tends to be more dense and fibrous in younger women, and more soft and fatty in older women (Kerlikowske, et al., 1996) .
In Walter and Day (1983) , it was found that sensitivity is negatively correlated with the sojourn time, Intuitively, when the tumor cell is just formed, the sensitivity is very small, while at the late stage, that is, the preclinical stage comes to an end and the clinical stage will start soon, the sensitivity is close to one. In Wu, et al. (2005) , the sensitivity was modeled as a function of age, while transition probability is agedependent as well. Previous result are extended by investigating changes in the sensitivity from simultaneous variation of age and time spent in the preclinical stage.
The Model
Consider a cohort of initially asymptomatic individuals who enroll in a screening program. The sensitivity is denoted by β(t,s|T), where t is the individual's age at the screening exam, s is the time duration that one has been stayed in the preclinical state, and T represents the sojourn time in the preclinical state. Define w(t)dt as the probability of a transition from S 0 to S p during (t, t+dt). Let q(t) be the probability density function of the sojourn
is the survivor function of the sojourn time in the preclinical state S p . Throughout this paper, the time variable t represents the participating individual's age. If random variables T and S are the duration times in S 0 and S p respectively, then an individual will enter the clinical state S c at age T+S, the probability density function of (T+S) is
I(t) is the observable incidence of clinical cases if no intervention exists.
Consider a cohort of women in the study group who are all aged t 0 at study entry, and a protocol for K ordered screening examinations occurring at ages 
given that she is already in the preclinical state. The probability that an individual in p S is detected at the first scheduled
The double integral in equation (1) (1 )
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The full likelihood for the study group across all ages is , , , 
(1 )
The age effect and the time spent in the preclinical state were modeled in the sensitivity in the following way. The sensitivity is associated with age by a logistic link, and it is associated with the time spent in the preclinical state by a linear function. Let
where t is an individual's age at the screening exam, s is the time one has spent in the preclinical state, T is the sojourn time in the preclinical state, and t is the average age at entry in the whole study group. If The transition probability density function w(t) is the instantaneous probability of a transition from S 0 to S p . The integral
represents a lifetime risk for a healthy female to transit into the preclinical state. According to the NCI's SEER database (Ries et al. 2002) , a woman's lifetime risk of being diagnosed with breast cancer is 15.7%, which is less than a woman's lifetime risk of entering the preclinical disease state. where x is the sojourn time, and κ and ρ are positive parameters representing the scale and location in the log logistic family. An advantage of this family over the exponential is that it has two parameters and is more robust in the tails. Figure 2: Posterior quantiles (5%, 50%, and 95%) of sensitivity and transition probability.
Another advantage of this family is that its relatively simple form is achieved for the survivor function and the hazard function. Its first moment can be calculated directly from
For the r-th moment to exist, r > κ is required. For justifications on how these age effect functions are chosen, see Wu, et al. (2005) .
Simulation Procedure and Results
The analysis of the HIP study data is now described based on the likelihood function and probability calculation derived above. In the proposed model, there are six unknown parameters, that is, ). , , , . For justifications of these ranges, see Wu, et al. (2005) .
Markov Chain Monte Carlo (MCMC) was used to generate a random sample from the joint posterior distribution of the parameters for Bayesian inference. The posterior simulation was partitioned into four sub-chains, sampling the posterior for The Bayesian posterior estimates of θ for the HIP study data are shown in Table 1 . Sensitivity at the end of the preclinical state appears to increase with age. If T s → , that is, if the time spent in the preclinical state s converges to the sojourn time T, then the sensitivity in the late stage of the preclinical state can be estimated. This trend is obvious from the quantile plot of the saved posterior samples of the parameters in Figure 1 . In the HIP data, the posterior mean sensitivity increases from 0.628 to 0.899 from ages 40 to 65 years, and the posterior standard error drops from 0.215 to 0.109. In fact, the posterior error of sensitivity was monotone decreasing as age increases.
The age-dependent transition probability is itself a sub-pdf from our model construction. The posterior density curve of the transition probability could be seen from Figure 1 . The transition probability is not a monotone function of age; it has a single maximum at age 64. If the posterior means for the parameters κ and ρ were used, then the posterior mean sojourn time is 4.06 years, with a mode of 1.70 years.
Discussion
The previous model in Wu, et al. (2005) is extended by adding one element in the sensitivity function, namely, the time spent in the preclinical state, with the sojourn time. Walter and Day (1983) found that the sensitivity and the sojourn time distribution were negatively correlated for a given incidence. Our modeling should be able to handle that problem, as our sensitivity was defined as a function of the sojourn time as well, and it was reciprocal to the sojourn time. More complicated models could be explored, but the computation time will be greatly increased, and simulation would take too long to be finished.
The result was compared with Wu, et al. (2005) . It was found that the late stage sensitivity was slightly higher, with a slightly smaller standard error. It was also found that the transition probability was changing less across different ages, with a slightly smaller standard error. However, the mean sojourn time is much longer than the previous result.
